We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

BioPerfectus Technologies

Bioperfectus Technologies Co., Ltd. is one of the leading molecular diagnostic solution providers in the global in-vi... read more Featured Products: More products

Download Mobile App





Bioperfectus Highlights Latest Innovations in Molecular Diagnostics

By LabMedica International staff writers
Posted on 31 Jul 2025

Jiangsu Bioperfectus Technologies Co. More...

, Ltd. (Shanghai, China) is participating in ADLM 2025, where the company is exhibiting its latest innovations in molecular diagnostics, along with its fast and reliable solutions for key infectious threats.

At this year’s ADLM, Bioperfectus is showcasing the SSP-GL01A fully automated NGS library preparation system that provides a flexible, fully-automated solution to standardized NGS library preparation. The easy-to-use system effectively reduces turnaround time and frees up laboratory staff, minimizing manual error and enhancing efficiency.

Bioperfectus is also highlighting SAW-48, its seamless sample-to-PCR solution that integrates cutting-edge mechanical, electronic, and software technologies. SAW-48 integrates sample loading, nucleic acid purification, and PCR setup functions in one instrument. The typical run duration is less than 45 minutes for 1-48 samples. Based on experienced magnetic separation technology, SAW-48 provides high-throughput automation combined with high performance. Also featuring at the show is the SSNP-2000B nucleic acid extraction system, which integrates new technologies such as machine, electricity, and computer software to enable automatic nucleic acid extraction of a maximum of 32 samples at one time.

Additionally, Bioperfectus is presenting its rapid diagnostic solutions for key infectious threats such as respiratory infections, Mpox (monkeypox), and vector-borne diseases. BioPerfectus offers a comprehensive flu diagnostic test portfolio ranging from POCT to Real-time PCR kits, ensuring labs have the tools to combat influenza viruses when they matter most. This includes the Allfastra SARS-CoV-2 / FluA / FluB / RSV Real Time PCR Kit, Respiratory Virus Panel (7) Real Time PCR Kit, Influenza A&B Rapid Test Kit, and Influenza Virus A/Influenza Virus B/H1N1 (2009)/ H3 Real Time PCR Kit (RUO). Bioperfectus is also highlighting its Monkeypox Virus Genotyping Real Time PCR Kit, an in vitro diagnostic test based on real-time PCR technology for the detection and identification of DNA from the West African clade and the Congo Basin (Central African) clade of Monkeypox virus.

Related Links:
Jiangsu Bioperfectus Technologies Co., Ltd.


Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Gold Member
Genetic Type 1 Diabetes Risk Test
T1D GRS Array
Anterior Nasal Specimen Collection Swabs
53-1195-TFS, 53-0100-TFS, 53-0101-TFS, 53-4582-TFS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Industry

view channel
Image: The LIAISON NES molecular point-of-care platform (Photo courtesy of Diasorin)

Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform

Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.